Stockscreener 앱 받기
1.92
28.00%
0.42
시간 외 거래:
1.90
-0.02
-1.04%
전일 마감가:
$1.50
열려 있는:
$1.65
하루 거래량:
4.34M
Relative Volume:
3.33
시가총액:
$311.87M
수익:
$400.57M
순이익/손실:
$9.21M
주가수익비율:
48.00
EPS:
0.04
순현금흐름:
$146.36M
1주 성능:
+15.66%
1개월 성능:
+46.56%
6개월 성능:
+105.94%
1년 성능:
-51.39%
1일 변동 폭
$1.61
$1.94
1주일 범위
$1.4705
$1.94
52주 변동 폭
$0.5271
$5.1288
아이언우드 제약 Stock (IRWD) Company Profile
명칭
Ironwood Pharmaceuticals Inc
전화
617-621-7722
주소
100 SUMMER STREET, SUITE 2300, BOSTON, MA
IRWD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.92 | 243.65M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
아이언우드 제약 Stock (IRWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | 개시 | Leerink Partners | Market Perform |
| 2024-08-08 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | 개시 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Wells Fargo | Overweight |
| 2023-11-09 | 개시 | Jefferies | Buy |
| 2023-09-28 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-02 | 개시 | CapitalOne | Overweight |
| 2022-04-22 | 개시 | Piper Sandler | Overweight |
| 2020-09-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | 개시 | Northland Capital | Outperform |
| 2019-07-10 | 재개 | Credit Suisse | Neutral |
| 2019-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | 업그레이드 | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-11-07 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-07-23 | 개시 | H.C. Wainwright | Sell |
| 2018-05-09 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2017-07-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-05-03 | 개시 | Wells Fargo | Outperform |
| 2017-04-07 | 재확인 | Mizuho | Buy |
| 2017-02-22 | 재확인 | Barclays | Equal Weight |
| 2016-11-04 | 재확인 | Mizuho | Buy |
| 2016-10-24 | 재확인 | Wedbush | Neutral |
| 2016-10-10 | 재확인 | Mizuho | Buy |
| 2016-09-27 | 재확인 | WallachBeth | Hold |
모두보기
아이언우드 제약 주식(IRWD)의 최신 뉴스
Ironwood surges 28% as beneficiary of partner AbbVie's Linzess Q3 sales (IRWD:NASDAQ) - Seeking Alpha
Ironwood Pharmaceuticals (IRWD) Expected to Announce Earnings on Thursday - MarketBeat
Live market analysis of Ironwood Pharmaceuticals Inc.July 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - newser.com
Will Ironwood Pharmaceuticals Inc. bounce back from current supportJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Is it time to cut losses on Ironwood Pharmaceuticals Inc.July 2025 Action & Weekly Top Stock Performers List - newser.com
Will Ironwood Pharmaceuticals Inc. (I76) stock split increase liquidityWeekly Risk Report & Stock Market Timing Techniques - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explained2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent moveMarket Growth Report & Pattern Based Trade Signal System - newser.com
Pattern recognition hints at Ironwood Pharmaceuticals Inc. upsideGlobal Markets & Weekly Stock Breakout Alerts - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominanceJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recoveryEarnings Overview Report & Growth Focused Entry Point Reports - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform tech sector in 2025Weekly Trend Report & AI Based Trade Execution Alerts - newser.com
Why Ironwood Pharmaceuticals Inc. stock is a must watch in 2025July 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock now2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Ironwood Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Will Ironwood Pharmaceuticals Inc. outperform the market2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Published on: 2025-10-28 05:42:32 - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Hold" by Analysts - MarketBeat
How to use a screener to detect Ironwood Pharmaceuticals Inc. breakoutsGap Down & Free Long-Term Investment Growth Plans - newser.com
Will Ironwood Pharmaceuticals Inc. stock reach all time highs in 2025Earnings Trend Report & Safe Entry Trade Signal Reports - Fundação Cultural do Pará
Real time breakdown of Ironwood Pharmaceuticals Inc. stock performance2025 Sector Review & Proven Capital Preservation Methods - newser.com
Aug Macro: Will Ironwood Pharmaceuticals Inc. stock recover faster than market2025 Bull vs Bear & Low Risk High Reward Trade Ideas - Fundação Cultural do Pará
아이언우드 제약 (IRWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이언우드 제약 주식 (IRWD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
3.18%
1.86%
자본화:
|
볼륨(24시간):